"The United States Food and Drug Administration (USFDA) may withhold approval of any new applications or supplements till the company addresses all issues raised by the agency," Jubilant Life Sciences said in a filing to the BSE.from Moneycontrol Business News https://ift.tt/2J02IW9
No comments:
Post a Comment